HIV-1 Group O Infection in Cameroon, 1986 to 1998

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2001 Jun 1

PMID 11384531

Citations 33

Authors

A Ayouba

P Mauclere

P M Martin

P Cunin

J Mfoupouendoun

B Njinku

S Souquieres

F Simon

Affiliations

Soon will be listed here.

Abstract

We report a survey of HIV-1 group O infection in Cameroon during 1986 to 1998. The prevalence of HIV-1/O decreased from 0.6% to 0.4%, while HIV-1/M increased from 19.2% to 31.5% from 1994 to 1998. We concluded that HIV-1/O infection is stable in Cameroon and may be declining slightly.

Citing Articles

A pilot investigation of the association between HIV-1 Vpr amino acid sequence diversity and the tryptophan-kynurenine pathway as a potential mechanism for neurocognitive impairment.

Asia L, Jansen Van Vuren E, Lindeque Z, Williams M Virol J. 2024; 21(1):47.

PMID: 38395987 PMC: 10893664. DOI: 10.1186/s12985-024-02313-1.

Conserved presence of G-quadruplex forming sequences in the Long Terminal Repeat Promoter of Lentiviruses.

Perrone R, Lavezzo E, Palu G, Richter S Sci Rep. 2017; 7(1):2018.

PMID: 28515481 PMC: 5435695. DOI: 10.1038/s41598-017-02291-1.

Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon.

De Oliveira F, Mourez T, Vessiere A, Ngoupo P, Alessandri-Gradt E, Simon F Retrovirology. 2017; 14(1):1.

PMID: 28086923 PMC: 5237259. DOI: 10.1186/s12977-016-0324-3.

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

Tebit D, Patel H, Ratcliff A, Alessandri E, Liu J, Carpenter C AIDS Res Hum Retroviruses. 2016; 32(7):676-88.

PMID: 26861573 PMC: 4931737. DOI: 10.1089/AID.2015.0318.

HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges.

Villabona-Arenas C, Domyeum J, Mouacha F, Butel C, Delaporte E, Peeters M Infect Genet Evol. 2015; 36:210-216.

PMID: 26371064 PMC: 4680975. DOI: 10.1016/j.meegid.2015.09.006.

References

Fluit A, Schmitz F . Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur J Clin Microbiol Infect Dis. 1999; 18(11):761-70. DOI: 10.1007/s100960050398. View

Jamal W, Rotimi V, Chugh T . An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait. J Hosp Infect. 1999; 43(1):49-56. DOI: 10.1053/jhin.1999.0608. View

Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J . Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000; 44(4):891-7. PMC: 89788. DOI: 10.1128/AAC.44.4.891-897.2000. View

Ambler R . The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980; 289(1036):321-31. DOI: 10.1098/rstb.1980.0049. View

Mercier J, Levesque R . Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob Agents Chemother. 1990; 34(8):1577-83. PMC: 171876. DOI: 10.1128/AAC.34.8.1577. View

G Williams J, Kubelik A, Livak K, Rafalski J, Tingey S . DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 1990; 18(22):6531-5. PMC: 332606. DOI: 10.1093/nar/18.22.6531. View

Nordmann P, Naas T . Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases. Antimicrob Agents Chemother. 1994; 38(1):104-14. PMC: 284404. DOI: 10.1128/AAC.38.1.104. View

Hall R, Brown H, Brookes D, Stokes H . Integrons found in different locations have identical 5' ends but variable 3' ends. J Bacteriol. 1994; 176(20):6286-94. PMC: 196970. DOI: 10.1128/jb.176.20.6286-6294.1994. View

Levesque C, Piche L, Larose C, Roy P . PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother. 1995; 39(1):185-91. PMC: 162507. DOI: 10.1128/AAC.39.1.185. View

10.

Chen H, Yuan M, Livermore D . Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J Med Microbiol. 1995; 43(4):300-9. DOI: 10.1099/00222615-43-4-300. View

11.

Vahaboglu H, Ozturk R, Aygun G, Coskunkan F, Yaman A, Kaygusuz A . Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother. 1997; 41(10):2265-9. PMC: 164104. DOI: 10.1128/AAC.41.10.2265. View

12.

Stokes H, OGorman D, Recchia G, Parsekhian M, Hall R . Structure and function of 59-base element recombination sites associated with mobile gene cassettes. Mol Microbiol. 1998; 26(4):731-45. DOI: 10.1046/j.1365-2958.1997.6091980.x. View

13.

Nordmann P, Guibert M . Extended-spectrum beta-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother. 1998; 42(2):128-31. DOI: 10.1093/jac/42.2.128. View

14.

Tosini F, Visca P, Luzzi I, Dionisi A, Pezzella C, Petrucca A . Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype typhimurium. Antimicrob Agents Chemother. 1998; 42(12):3053-8. PMC: 105998. DOI: 10.1128/AAC.42.12.3053. View

15.

Poirel L, Naas T, Guibert M, Chaibi E, Labia R, Nordmann P . Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene. Antimicrob Agents Chemother. 1999; 43(3):573-81. PMC: 89162. DOI: 10.1128/AAC.43.3.573. View

16.

Tribuddharat C, Fennewald M . Integron-mediated rifampin resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1999; 43(4):960-2. PMC: 89236. DOI: 10.1128/AAC.43.4.960. View

17.

Poirel L, Guibert M, Bellais S, Naas T, Nordmann P . Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients. Antimicrob Agents Chemother. 1999; 43(5):1098-104. PMC: 89117. DOI: 10.1128/AAC.43.5.1098. View

18.

Naas T, Poirel L, Karim A, Nordmann P . Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiol Lett. 1999; 176(2):411-9. DOI: 10.1111/j.1574-6968.1999.tb13691.x. View

19.

Mimoz O, Elhelali N, Leotard S, Jacolot A, Laurent F, Samii K . Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa. J Antimicrob Chemother. 1999; 44(1):91-7. DOI: 10.1093/jac/44.1.91. View

20.

Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P . Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother. 2000; 44(3):622-32. PMC: 89737. DOI: 10.1128/AAC.44.3.622-632.2000. View